Additionally, reduced CPS1-IT1 levels represent an independent biomarker for disease-free survival (DFS) (HR = 0.55, 95%CI 0.34–0.87, p = 0.011) and OS (HR = 0.57, 95%CI 0.34–0.98, p = 0.042) in hepatocellular carcinoma patients [61]. The gene discussed is CPS1; the disease is hepatocellular carcinoma.